SCHEMBL13614493

SCHEMBL13614493

C=Cc1ccc(-c2ccc(C)c(F)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
ERN1 O75460 1/20 0.41
NISCH Q9Y2I1 1/20 0.40
KIF11 P52732 1/20 0.39
HDAC8 Q9BY41 1/20 0.38
KMO O15229 2/20 0.36
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
TP53 P04637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TUBB1 Q9H4B7 1/20 0.34
KCNH2 Q12809 2/20 0.34
AKR1B10 O60218 1/20 0.34
AKR1C4 P17516 1/20 0.34
AKR1C1 Q04828 1/20 0.34
TSHR P16473 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13614803 0.84 TP53 (0.45) ALDH1A1NISCHHDAC8KMOTP53
SCHEMBL13703909 0.83 NISCH (0.50) ALDH1A1ERN1NISCHKIF11KMO
SCHEMBL12377626 0.81 NISCH (0.52) ALDH1A1ERN1NISCHKMOAKR1C3
SCHEMBL4567622 0.79 ALDH1A1 (0.37) ALDH1A1KIF11HDAC8AKR1C3AKR1C2
SCHEMBL172021 0.79 PDE3B (0.41) ALDH1A1KIF11HDAC8TP53TDP1
SCHEMBL4427979 0.79 PDE3B (0.41) ALDH1A1KIF11HDAC8TP53TDP1
SCHEMBL15834804 0.78 ALDH1A1 (0.44) ALDH1A1KIF11HDAC8TSHRESR1
SCHEMBL12428855 0.78 NISCH (0.39) ERN1NISCHKMOAKR1C3AKR1C2
SCHEMBL10018704 0.77 NISCH (0.46) ERN1NISCHKMOAKR1C3AKR1C2
SCHEMBL10014184 0.77 NISCH (0.46) ERN1NISCHKMOAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103347864-B Pyrimidone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA 2 葛兰素集团有限公司 2016-08-10 CN disclosed
EP-2116522-A1 PENTACYCLIC LIQUID CRYSTAL COMPOUND HAVING CF<SB>2</SB>O BONDING GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY Chisso Corporation (JP) 2009-11-11 EP disclosed